Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official

'The data is coming in, and it looks very encouraging that the US-approved vaccines do have effectiveness against this variant called B1617,' Dr Francis Collins, Director of the National Institute of Science said

Press Trust of India May 13, 2021 15:37:23 IST
Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official

Representational image. AP

Washington: COVID-19 vaccines approved by the United States like Pfizer, Moderna, and Johnson and Johnson have effectiveness against the B1617 variant of the virus that is predominant in India, which is experiencing one of the worst outbreaks of the pandemic, a top American health official said.

The observation is based on the latest data about the variant and the three major vaccines approved by the United States, said Dr Francis Collins, Director of the National Institute of Science.

“The data is coming in, and it looks very encouraging that the US-approved vaccines, the Pfizer, the Moderna, the J&J, do have effectiveness against this variant called B1617,” Collins told the media.

“It's a little less effective in that case than some of the others, but it looks like it ought to be good enough to make Americans protected. And that's really a good thing to hear,” he said in response to a question.

Early this week, the World Health Organization classified the B1617 SARS-CoV-2 variant, which was first detected in India, as a variant of concern. The WHO said that evidence showed B1617 was more transmissible.

Updated Date:

also read

COVID-19 update: New cases fall below one lakh after 63 days; daily positivity rate at 4.62%
India

COVID-19 update: New cases fall below one lakh after 63 days; daily positivity rate at 4.62%

The COVID-19 toll rose to 3,51,309 on Tuesday with 2,123 deaths. The Centre said this single-day figure is the lowest in 47 days

Coronavirus News Updates: Over 31 lakh vaccine doses administered today, total crosses 23.5 cr, says Centre
India

Coronavirus News Updates: Over 31 lakh vaccine doses administered today, total crosses 23.5 cr, says Centre

Coronavirus News Updates: Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh and West Bengal have administered more than 10 lakh beneficiaries of the age group 18-44 years for the first dose of vaccine

India reports one lakh new COVID-19 cases today; lowest single-day tally in 61 days, says Centre
India

India reports one lakh new COVID-19 cases today; lowest single-day tally in 61 days, says Centre

The Union health ministry added that the number of deaths reported in the past 24 hours — 2,472 — is the lowest in 45 days